Kate Harvey

Role: Staff Scientist
Lab/Group: Swarbrick Lab

Selected publications

See all publications

2024
The Journal of Pathology10.1002/path.6250
Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Braydon Meyer, Clare Stirzaker, Sonny Ramkomuth, Kate Harvey, Belinda Chan, Cheok Soon Lee, Rooshdiya Karim, Niantao Deng, Kelly A Avery-Kiejda, Rodney J Scott, Sunil Lakhani, Stephen Fox, Elizabeth Robbins, Joo-Shik Shin, Jane Beith, Anthony Gill, Loretta Sioson, Charles Chan, Mrudula Krishnaswamy, Caroline Cooper, Sanjay Warrier, Cindy Mak, John Ej Rasko, Charles G Bailey, Alexander Swarbrick, Susan J Clark, Sandra O'Toole, Ruth Pidsley
2023
Clinical Cancer Research : An Official Journal of the American Association for Cancer Research10.1158/1078-0432.CCR-22-3350
Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.
Kiranj Chaudagar, Hanna M Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela Bynoe, Catherine Drovetsky, Ani Solanki, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan Schürer, Alex Swarbrick, David B Sykes, Akash Patnaik
2022
Breast Cancer Research : BCR10.1186/s13058-022-01540-0
Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
Niantao Deng, Andre Minoche, Kate Harvey, Meng Li, Juliane Winkler, Andrei Goga, Alex Swarbrick
2021
Clinical Epigenetics10.1186/s13148-021-01210-6
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Braydon Meyer, Samuel Clifton, Warwick Locke, Phuc-Loi Luu, Qian Du, Dilys Lam, Nicola J Armstrong, Beena Kumar, Niantao Deng, Kate Harvey, Alex Swarbrick, Vinod Ganju, Susan J Clark, Ruth Pidsley, Clare Stirzaker
2021
Nature10.1038/s41586-021-03835-2
Colorimetric histology using plasmonically active microscope slides.
Eugeniu Balaur, Sandra O' Toole, Alex J Spurling, G Bruce Mann, Belinda Yeo, Kate Harvey, Catherine Sadatnajafi, Eric Hanssen, Jacqueline Orian, Keith A Nugent, Belinda S Parker, Brian Abbey

See all Garvan publications

Explore our research

Our impact

Our people

News and resources

About us

Support Us

Kate Harvey

Selected publications

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.

Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.

Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.

Colorimetric histology using plasmonically active microscope slides.

Garvan researchers selected as Eureka Prize finalists